Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vaccinia 1Liver Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 130Carboplatin 106Paclitaxel 65Cisplatin 61Gemcitabine 59Pemetrexed 57Bevacizumab 54Docetaxel 49Fluorouracil 43Oxaliplatin 41atezolizumab 37Dexamethasone 36Leucovorin 34Cetuximab 33130-nm albumin-bound paclitaxel 33Nivolumab 30Cyclophosphamide 30Prednisone 29Rituximab 28Capecitabine 28durvalumab 27Fulvestrant 24Lenalidomide 22enzalutamide 21Letrozole 21Irinotecan 21venetoclax 20Doxorubicin 19ribociclib 18pomalidomide 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Granulocyte-Macrophage Colony-Stimulating Factor × 30 days × Clear all
NCT00629759 2026-05-19

A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma

SillaJen, Inc.

Phase 1 Completed
14 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Vaccinia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡